http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2561039-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71531ab580ad33a4c335530b2b1f8ef9 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate | 2014-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88591e192f4d38d651ff8526fbaaea1c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a82f8ef0633a0d59632eee96224cbc2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5ad1c0ad8afd45929bdbf55d9a36cf1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97c3ff6246594ef93cf577e252aa2946 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78c93e5eb75397f27fcfd275bd2b1896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_125e777a61347369f1e02b4e35b4a659 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f0957428f93880a5d2e3ca60ea0f255 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f26ec1bafc703641be9ecf8eb0e44b9b |
| publicationDate | 2015-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2561039-C2 |
| titleOfInvention | Method for estimation of fatty tissue inflammation activity in case of abdominal obesity |
| abstract | FIELD: medicine. n SUBSTANCE: invention relates to field of medicine, namely to cardiology and endocrinology, and describes method of diagnosing inflammation in fatty tissue in case of obesity. Method is characterised by the fact that concentration of neopterin is determined in serum of patients' venous blood by solid-phase enzyme-linked immunosorbent assay (ELISA) and if concentration of neopterine is higher or equals 10 nmol/l, inflammation of fatty tissue is diagnosed. n EFFECT: invention can be applied for estimation of fatty tissue inflammation activity in case of abdominal obesity, which represents basic component of metabolic syndrome (MS), and makes it possible to control clinical course of MS and efficiency of performed therapy. n 3 dwg, 2 tbl |
| priorityDate | 2014-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 76.